{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:40:24Z","timestamp":1774543224135,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12975-025-01387-5","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:11:39Z","timestamp":1760400699000},"page":"2339-2349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of MR-proANP Circulating Levels with Ischemic Stroke of Cardioembolic Etiology: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8885-2130","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Sousa-Costa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0578-3982","authenticated-orcid":false,"given":"Henrique","family":"Moura","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1003-580X","authenticated-orcid":false,"given":"Joana","family":"Ponte","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2854-7844","authenticated-orcid":false,"given":"Benedita","family":"Couto-Viana","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Pinheiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-4312","authenticated-orcid":false,"given":"Paulo","family":"Castro-Chaves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7863-1991","authenticated-orcid":false,"given":"Mariana","family":"Pintalhao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1387_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1204\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","journal-title":"Lancet"},{"key":"1387_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14737175.2023.2192403","volume":"23","author":"D Yang","year":"2023","unstructured":"Yang D, Elkind MSV. Current perspectives on the clinical management of cryptogenic stroke. Expert Rev Neurother. 2023;23:213\u201326. https:\/\/doi.org\/10.1080\/14737175.2023.2192403.","journal-title":"Expert Rev Neurother"},{"key":"1387_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/23969873221076971","volume":"7","author":"NN Hariharan","year":"2022","unstructured":"Hariharan NN, Patel K, Sikder O, et al. Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: a systematic review and meta-analysis. Eur Stroke J. 2022;7:92\u20138. https:\/\/doi.org\/10.1177\/23969873221076971.","journal-title":"Eur Stroke J"},{"key":"1387_CR4","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.014","volume":"23","author":"HL Yang","year":"2014","unstructured":"Yang HL, Lin YP, Long Y, et al. Predicting cardioembolic stroke with the B-type natriuretic peptide test: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2014;23:1882\u20139. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.02.014.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1387_CR5","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1161\/STROKEAHA.114.008311","volume":"46","author":"V Llombart","year":"2015","unstructured":"Llombart V, Antolin-Fontes A, Bustamante A, et al. B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis. Stroke. 2015;46:1187\u201395. https:\/\/doi.org\/10.1161\/STROKEAHA.114.008311.","journal-title":"Stroke"},{"key":"1387_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jama.2023.27188","volume":"331","author":"H Kamel","year":"2024","unstructured":"Kamel H, Longstreth WT Jr, Tirschwell DL, et al. Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial. JAMA. 2024;331:573\u201381. https:\/\/doi.org\/10.1001\/jama.2023.27188.","journal-title":"JAMA"},{"key":"1387_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJM199807303390507","volume":"339","author":"ER Levin","year":"1998","unstructured":"Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321\u20138. https:\/\/doi.org\/10.1056\/NEJM199807303390507.","journal-title":"N Engl J Med"},{"key":"1387_CR8","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.jacc.2010.05.049","volume":"56","author":"JG Smith","year":"2010","unstructured":"Smith JG, Newton-Cheh C, Almgren P, et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol. 2010;56:1712\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.049.","journal-title":"J Am Coll Cardiol"},{"key":"1387_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jacc.2010.02.071","volume":"56","author":"M Katan","year":"2010","unstructured":"Katan M, Fluri F, Schuetz P, et al. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. J Am Coll Cardiol. 2010;56:1045\u201353. https:\/\/doi.org\/10.1016\/j.jacc.2010.02.071.","journal-title":"J Am Coll Cardiol"},{"key":"1387_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1373\/clinchem.2003.021204","volume":"50","author":"NG Morgenthaler","year":"2004","unstructured":"Morgenthaler NG, Struck J, Thomas B, Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem. 2004;50:234\u20136. https:\/\/doi.org\/10.1373\/clinchem.2003.021204.","journal-title":"Clin Chem"},{"key":"1387_CR11","doi-asserted-by":"crossref","unstructured":"Hotter B, Hoffmann S, Ulm L, et al. (2020) Inflammatory and stress markers predicting pneumonia, outcome, and etiology in patients with stroke: Biomarkers for predicting pneumonia, functional outcome, and death after stroke. Neurol Neuroimmunol Neuroinflamm 710.1212\/NXI.0000000000000692","DOI":"10.1212\/NXI.0000000000000692"},{"key":"1387_CR12","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jacc.2022.01.042","volume":"79","author":"J Schweizer","year":"2022","unstructured":"Schweizer J, Arnold M, Konig IR, et al. Measurement of midregional pro-atrial natriuretic peptide to discover atrial fibrillation in patients with ischemic stroke. J Am Coll Cardiol. 2022;79:1369\u201381. https:\/\/doi.org\/10.1016\/j.jacc.2022.01.042.","journal-title":"J Am Coll Cardiol"},{"key":"1387_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.str.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35\u201341. https:\/\/doi.org\/10.1161\/01.str.24.1.35.","journal-title":"Stroke"},{"key":"1387_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033134","volume":"13","author":"H Ikenouchi","year":"2024","unstructured":"Ikenouchi H, Saito S, Ishiyama H, et al. Predictive value of midregional pro-atrial natriuretic peptide for cardioembolic stroke in hyperacute ischemic stroke. J Am Heart Assoc. 2024;13: e033134. https:\/\/doi.org\/10.1161\/JAHA.123.033134.","journal-title":"J Am Heart Assoc"},{"key":"1387_CR15","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/STROKEAHA.120.029333","volume":"51","author":"M Arnold","year":"2020","unstructured":"Arnold M, Nakas C, Luft A, et al. Independent prognostic value of MRproANP (midregional proatrial natriuretic peptide) levels in patients with stroke is unaltered over time. Stroke. 2020;51:1873\u20135. https:\/\/doi.org\/10.1161\/STROKEAHA.120.029333.","journal-title":"Stroke"},{"key":"1387_CR16","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1212\/WNL.0000000000004922","volume":"90","author":"GM De Marchis","year":"2018","unstructured":"De Marchis GM, Schneider J, Weck A, et al. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke. Neurology. 2018;90:e455\u201365. https:\/\/doi.org\/10.1212\/WNL.0000000000004922.","journal-title":"Neurology"},{"key":"1387_CR17","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/STROKEAHA.115.011392","volume":"47","author":"M Katan","year":"2016","unstructured":"Katan M, Moon YP, Paik MC, et al. Procalcitonin and midregional proatrial natriuretic peptide as markers of ischemic stroke: the Northern Manhattan Study. Stroke. 2016;47:1714\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.115.011392.","journal-title":"Stroke"},{"key":"1387_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000363279","volume":"37","author":"J Berntsson","year":"2014","unstructured":"Berntsson J, Zia E, Borne Y, et al. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke. Cerebrovasc Dis. 2014;37:444\u201350. https:\/\/doi.org\/10.1159\/000363279.","journal-title":"Cerebrovasc Dis"},{"key":"1387_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00392-020-01608-x","volume":"109","author":"A Sepehri Shamloo","year":"2020","unstructured":"Sepehri Shamloo A, Bollmann A, Dagres N, et al. Natriuretic peptides: biomarkers for atrial fibrillation management. Clin Res Cardiol. 2020;109:957\u201366. https:\/\/doi.org\/10.1007\/s00392-020-01608-x.","journal-title":"Clin Res Cardiol"},{"key":"1387_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214415","author":"R Sarzani","year":"2022","unstructured":"Sarzani R, Allevi M, Di Pentima C, et al. Role of cardiac natriuretic peptides in heart structure and function. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232214415.","journal-title":"Int J Mol Sci"},{"key":"1387_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ejhf.1494","volume":"21","author":"C Mueller","year":"2019","unstructured":"Mueller C, McDonald K, de Boer RA, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21:715\u201331. https:\/\/doi.org\/10.1002\/ejhf.1494.","journal-title":"Eur J Heart Fail"},{"key":"1387_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-2796.2009.02135.x","volume":"267","author":"M Potocki","year":"2010","unstructured":"Potocki M, Breidthardt T, Reichlin T, et al. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure. J Intern Med. 2010;267:119\u201329. https:\/\/doi.org\/10.1111\/j.1365-2796.2009.02135.x.","journal-title":"J Intern Med"},{"key":"1387_CR23","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1373\/clinchem.2004.032490","volume":"50","author":"M Ala-Kopsala","year":"2004","unstructured":"Ala-Kopsala M, Magga J, Peuhkurinen K, et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem. 2004;50:1576\u201388. https:\/\/doi.org\/10.1373\/clinchem.2004.032490.","journal-title":"Clin Chem"},{"key":"1387_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012277","volume":"97","author":"K Cui","year":"2018","unstructured":"Cui K, Huang W, Fan J, Lei H. Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction. Medicine (Baltimore). 2018;97: e12277. https:\/\/doi.org\/10.1097\/MD.0000000000012277.","journal-title":"Medicine (Baltimore)"},{"key":"1387_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/ajh.2009.8","volume":"22","author":"M Khaleghi","year":"2009","unstructured":"Khaleghi M, Saleem U, Morgenthaler NG, et al. Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension. Am J Hypertens. 2009;22:425\u201331. https:\/\/doi.org\/10.1038\/ajh.2009.8.","journal-title":"Am J Hypertens"},{"key":"1387_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/14779072.2023.2160319","volume":"21","author":"SE Choi","year":"2023","unstructured":"Choi SE, Sagris D, Hill A, et al. Atrial fibrillation and stroke. Expert Rev Cardiovasc Ther. 2023;21:35\u201356. https:\/\/doi.org\/10.1080\/14779072.2023.2160319.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1387_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tcm.2021.12.001","volume":"33","author":"I Escudero-Martinez","year":"2023","unstructured":"Escudero-Martinez I, Morales-Caba L, Segura T. Atrial fibrillation and stroke: a review and new insights. Trends Cardiovasc Med. 2023;33:23\u20139. https:\/\/doi.org\/10.1016\/j.tcm.2021.12.001.","journal-title":"Trends Cardiovasc Med"},{"key":"1387_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112486","volume":"9","author":"RB Schnabel","year":"2014","unstructured":"Schnabel RB, Wild PS, Wilde S, et al. Multiple biomarkers and atrial fibrillation in the general population. PLoS ONE. 2014;9: e112486. https:\/\/doi.org\/10.1371\/journal.pone.0112486.","journal-title":"PLoS ONE"},{"key":"1387_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1177\/2047487317693948","volume":"24","author":"J Berntsson","year":"2017","unstructured":"Berntsson J, Smith JG, Nilsson PM, et al. Pro-atrial natriuretic peptide and prediction of atrial fibrillation and stroke: the Malmo Preventive Project. Eur J Prev Cardiol. 2017;24:788\u201395. https:\/\/doi.org\/10.1177\/2047487317693948.","journal-title":"Eur J Prev Cardiol"},{"key":"1387_CR30","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.3390\/jcm12216830","volume":"12","author":"V Schutz","year":"2023","unstructured":"Schutz V, Dougoud S, Bracher K, et al. The role of electrocardiographic markers for predicting atrial fibrillation in patients with acute ischemic stroke: data from the BIOSIGNAL cohort study. J Clin Med. 2023;12:6830. https:\/\/doi.org\/10.3390\/jcm12216830.","journal-title":"J Clin Med"},{"key":"1387_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209625","volume":"103","author":"AC Cameron","year":"2024","unstructured":"Cameron AC, Arnold M, Katsas G, et al. Natriuretic peptides to classify risk of atrial fibrillation detection after stroke: analysis of the BIOSIGNAL and PRECISE cohort studies. Neurology. 2024;103: e209625. https:\/\/doi.org\/10.1212\/WNL.0000000000209625.","journal-title":"Neurology"},{"key":"1387_CR32","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1002\/ehf2.14089","volume":"9","author":"M Li","year":"2022","unstructured":"Li M, Ning Y, Tse G, et al. Atrial cardiomyopathy: from cell to bedside. ESC Heart Fail. 2022;9:3768\u201384. https:\/\/doi.org\/10.1002\/ehf2.14089.","journal-title":"ESC Heart Fail"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-025-01387-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:02:52Z","timestamp":1762632172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-025-01387-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s12975-025-01387-5","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}